Clinical Trial Update: Interest of Famotidine in Children With Sickle Cell Disease [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 clinical trial evaluating famotidine for sickle cell disease in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Famotidine (famotidine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sickle Cell Disease | Phase 2, Phase 3 | Status: COMPLETED